Federal Register / Vol. 62, No. 206 / Friday, October 24, 1997 / Notices 55413

Dated October 16, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 97–28185 Filed 10–23–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following meeting

of the National Cancer Institute Initial

Review Group:

Agenda/Purpose: To review and evaluate

grant applications.

Committee Name: Subcommittee F—

Manpower and Training.

Date: November 12–14, 1997.

Time: November 12—6:30 p.m. to Recess;

November 13 and 14—8 a.m. to

Adjournment.

Place: The Holiday Inn—Georgetown, 2101

Wisconsin Avenue, NW, Washington, DC

20007.

Contact Person: Mary Bell, Ph.D., Scientific

Review Administrator, National Cancer

Institute, NIH, 6130 Executive Blvd., EPN,

Room 611A, Bethesda, MD 20892–7403,

Telephone: 301–496–7978.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: October 16, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 97–28186 Filed 10–23–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Cancer Institute Special

Emphasis Panel (SEP) meeting:

Name of SEP: AIDS—Oncology Clinical

Sciences Development Program.

Date: November 6, 1997.

Time: 8:30 a.m. to 5 p.m.

Place: Executive Plaza North, Room 640,

6130 Executive Boulevard, Bethesda, MD

20892.

Contact Person: Lalita Palekar, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, 6130 Executive

Boulevard, EPN, Room 622B, Bethesda, MD

20892–7405; Telephone: 301/496–7575.

Purpose/Agenda: To review and evaluate

responses to a Request for Application.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: October 16, 1997.

LaVerne Y. Springfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 97–28187 Filed 10–23–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following meeting

of the National Cancer Institute Initial

Review Group:

Agenda/Purpose: To review, discuss and

evaluate grant applications.

Name of Subcommittee: Subcommittee H–

Clinical Groups.

Date: December 9–10, 1997.

Time: 8 a.m. to Adjournment.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: John L. Meyer, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, 6130 Executive Blvd.,

North, Room 611C, Bethesda, MD 20892–

7403; Telephone: 301/496–7721.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: October 16, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 97–28188 Filed 10–23–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the meetings of the

Board of Scientific Counselors, National

Cancer Institute.

The meetings will be open to the

public as indicated below, with

attendance by the public limited to

space available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

contact Mrs. Linda Quick-Cameron,

Committee Management Officer, at (301)

496–5708 in advance of the meeting.

A portion of the meetings will be

closed to the public in accordance with

the provision set forth in sec. 552b(c)(6),

Title 5, U.S.C. and sec. 10(d) of Pub. L.

92–463, for the review, discussion, and

evaluation of individual programs and

projects. These discussions will include

consideration of personnel